Početna › Multipla skleroza › Alabama
Kliničke studije za Multipla skleroza u državi Alabama
8 studija za Multipla skleroza traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Alabama Neurology Associates, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06782490Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 18 do 64 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07475377A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Birmingham
- TG Therapeutics Investigational Trial Site, Cullman
- TG Therapeutics Investigational Trial Site, Huntsville
- i još 1
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- North Central Neurology Associates- Site Number : 8401100, Cullman
- Alabama Neurology Associates- Site Number : 8400115, Homewood
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Alabama Neurology Associates PC, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07225504Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
- University of Alabama at Birmingham Medical Center, Birmingham
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 2. lip 2026. · NCT03759522Care in Multiple Sclerosis (MS)
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT07011914Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.